The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / The Rheumatologist: March 2019

The Rheumatologist: March 2019

Lightspring / shutterstock.com

Recent Research Probes Smoking & the Risk for Autoimmune Disease

March 18, 2019 • By Vanessa Caceres

The Benefits of Blood Money: OxyContin & Ethics

March 18, 2019 • By Philip Seo

The ACR De-Fragments & Analyzes Its Data to Identify Member Needs

March 18, 2019 • By Paula Marchetta, MD, MBA

The Diagnostic View: Ultrasound of a Child’s Sore Knee

March 19, 2019 • By Clara Lin, MD, RhMSUS

New Study: Does Urate-Lowering Therapy Reduce Gout-Patient Mortality?

New Study: Does Urate-Lowering Therapy Reduce Gout-Patient Mortality?

March 18, 2019 • By Ruth Jessen Hickman, MD

The History & Future of Anti-Citrullinated Protein Antibodies (ACPAs)

March 18, 2019 • By Ruth Jessen Hickman, MD

Research Suggests Th17 Cells Have Microbiota-Dependent Role in RA

March 18, 2019 • By Kathy Holliman

tanuha2001 / shutterstock.com

Fellows Forum: Helpful Twitter Follows & Chats for Fellows in Training

March 18, 2019 • By Kanika Monga, MD

Fellows Forum: Keep Up with the Literature & Organize Your Learning

March 19, 2019 • By Tyler Williams, MD, with Mike Putman, MD

Paul Adam, MSW, In the Spotlight

March 19, 2019 • By Kelly Tyrrell

Draft Guidelines & Recommendations for Juvenile Idiopathic Arthritis

March 19, 2019 • By Lara C. Pullen, PhD

Calcineurin Inhibitor Pain Syndrome: A Case Report & Literature Review

March 18, 2019 • By Priyanka Iyer, MD, MPH

A Case Study in Sweet’s Syndrome with Pulmonary Involvement

March 19, 2019 • By Lara C. Pullen, PhD

State-of-the-Art Approaches to Rheumatic Disease Diagnosis, Management & Treatment

March 19, 2019 • By Lara C. Pullen, PhD

The Latest on Epigenetics in Immune-Mediated Disease

March 19, 2019 • By Lara C. Pullen, PhD

Links Between Gut Bacteria and Rheumatoid Arthritis

March 19, 2019 • By Susan Bernstein

Research Shows Genetic Links in ANCA-Associated Vasculitis

March 19, 2019 • By Lara C. Pullen, PhD

Destructive Arthritis: From Prevention to Progression to Remission

March 19, 2019 • By Lara C. Pullen, PhD

Living Well with Scleroderma

March 19, 2019 • By Lara C. Pullen, PhD

Pediatric Uveitis in the Biologic Age: Risk Factors, Treatment & Outcomes

March 19, 2019 • By Lara C. Pullen, PhD

Treating Lupus: Strategies, Treat to Target & Biologics

March 19, 2019 • By Lara C. Pullen, PhD

Antiphospholipid Antibody Syndrome: Much Remains to be Learned

March 19, 2019 • By Lara C. Pullen, PhD

Biosimilars: How Do They Affect Patient Care & Safety?

March 19, 2019 • By Lara C. Pullen, PhD

Draft Classification Criteria for IgG4-Related Disease Introduced

March 19, 2019 • By Lara C. Pullen, PhD

To Bridge Health Disparities, Diagnose Lupus Early & Improve Access

March 19, 2019 • By Susan Bernstein

Disaster Preparedness in Rheumatology—Are You Ready?

March 19, 2019 • By Lara C. Pullen, PhD

Disease Mimicry: Genetic Diseases Can Produce Rheumatic Symptoms

March 19, 2019 • By Lara C. Pullen, PhD

Research Is Advancing Our Understanding of Gout & Hyperuricemia

March 19, 2019 • By Lara C. Pullen, PhD

The Latest on Vaccinations, Leprosy & Lyme Disease

March 19, 2019 • By Lara C. Pullen, PhD

Insights on the Diagnosis & Treatment of Low Back & Hip Pain

March 19, 2019 • By Susan Bernstein

Osteoporosis Experts Discuss Bisphosphonates, Chronic Kidney Disease

March 19, 2019 • By Lara C. Pullen, PhD

Dr. Sara Alehashemi: Rheumatologist, Researcher & Badminton Player

March 18, 2019 • By Carol Patton

Biosimilar ABP 798 Promising for RA

February 13, 2019 • By Michele B. Kaufman, PharmD, BCGP

Canada Approves Erelzi for PsA; Plus FDA Moves to Increase Access to Naloxone

February 4, 2019 • By Michele B. Kaufman, PharmD, BCGP

Foundation Earns Coveted 4-Star Rating from Charity Navigator for 10th Consecutive Year

March 18, 2019 • By From the College

Applications Invited for Arthritis & Rheumatology Editor in Chief

March 18, 2019 • By From the College

2019 RheumPAC Resolutions

January 17, 2019 • By Zachary Wallace, MD, MSc

Training Is the Path for Documentation & Coding Improvement

February 22, 2019 • By From the College

What Do JIA Patients Experience? A New Case Study from the ARP Practice Committee

January 31, 2019 • By Talitha Cox, OT, MA, on behalf of the ARP Practice Committee

Coding Corner Question: Use Level 3 or 4 for RA/Gout Patient?

March 11, 2019 • By From the College

Coding Corner Answer: Use Level 3 or 4 for RA/Gout Patient?

March 11, 2019 • By From the College

« Return to the Issue Archive

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)